Product Details
| Product Name:
GDC-4379 |
CAS No.:
2252277-73-7 |
| Supply Ability:
10g |
Release date:
2025/10/27 |
Product Introduction
Bioactivity
| Name | GDC-4379 |
| Description | GDC-4379, a JAK1 inhibitor, is used to study asthma. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Inhibitors Related | Delgocitinib | Deucravacitinib | RO8191 | Ruxolitinib | Atinvicitinib | Tofacitinib Citrate | CEP-33779 | Ruxolitinib phosphate | JAK-IN-10 | Fedratinib | Upadacitinib | Lentinan |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
CAS:2376824-99-4
$0.00 / 5mg
-
CAS:1788063-52-4
$165.00 / 1mg
-
CAS:2238822-07-4
$1250.00 / 25mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$747.00/10mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-10-27 |
|
|
$33.00/2mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-11-09 |
|
|
$1.10/1g |
VIP5Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2021-05-08 |
United States